The Health Subcommittee of the House of Representatives’ Energy and Commerce Committee held a markup hearing on May 17, 2023 to discuss a series of bills relating to transparency and competition in [...]
Next week, FTLF partners Jaqueline “Jacki” Leifer, Dianne K. Pledgie, Jason B. Reddish and Carrie Riley will speak on current compliance and 340B Program challenges at the Massachusetts League of Community Health [...]
Next week, FTLF Partner Jason Reddish will participate in the 340B Coalition Winter Conference in San Diego, CA, where he will provide updates on the 340B Program and compliance concerns for covered [...]
Next week, FTLF attorneys Martin Bree, Molly Evans, Matt Freedus, Susannah Vance Gopalan, Jason Reddish and Ted Waters will speak at the National Association of Community Health Centers’ (NACHC) Policy & Issues [...]
The United States Court of Appeals for the Third Circuit ruled on Monday in favor of drug manufacturers AstraZeneca, Sanofi and Novo Nordisk in their challenge against attempts by the Health Resources [...]
FTLF Partner Jason Reddish will be a co-presenter at the RWC-340B Grantees Conference, on October 18, 2022. Mr. Reddish will co-lead a plenary session entitled “Responding to Contract Pharmacy Restrictions” from 3:45-4:45 [...]
On June 15, 2022, the United States Supreme Court issued a unanimous ruling (“Decision”) handing a substantial win to hospitals participating in the 340B program. In 2018, the Centers for Medicare and [...]
FTLF’s 340B/Pharmacy Partners Michael B. Glomb and Jason B. Reddish will speak at the Annual 2022 340B Coalition Winter Conference next week in San Diego, CA. During the three-day conference, FTLF Partners will participate in the following sessions: Recapping [...]
FTLF Partner Jason Reddish will speak at three sessions during the Annual 340B Coalition Summer Conference. His presentations include: Jul 21, 2021 at 1:00PM - 1:50PM States Blazing a Trail Across the [...]
On December 10, 2020, the Supreme Court ruled in a unanimous decision (8-0) in Rutledge v. Pharmaceutical Care Management Association (PCMA)[1] that an Arkansas law that requires Pharmacy Benefit Managers (PBMs) to reimburse [...]
